PDS Biotechnology Corp-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:PDS Biotechnology Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013959
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PDS Biotechnology Corp (PDS Biotechnology) is a biopharmaceutical company that develops immunotherapies and vaccines for cancer and infectious disease. The company uses versamune technology, which is immunostimulatory nanoparticle vaccine platform used for the development of cancer immunotherapies and t-cell vaccines. Its products are used for treatment of HPV pre-cancer, head and neck cancer, ovarian cancer, pandemic influenza, cervical cancer and breast cancer, among others. The company also partners with cancer research institutes and biotechnology companies. PDS Biotechnology is headquartered in North Brunswick, New Jersey, the US.

PDS Biotechnology Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
PDS Biotechnology Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
PDS Biotech Raises USD1 Million in Venture Financing 10
PDS Biotech Raises Funds Through Venture Financing 11
PDS Biotech Raises Funds Through Venture Financing 12
Private Equity 13
NetScientific Invests in PDS Biotech 13
Partnerships 14
PDS Biotech Enters into Agreement with Merck 14
PDS Biotechnology Enters into R&D Agreement with National Cancer Institute 15
Licensing Agreements 16
PDS Biotechnology Enters Into Licensing Agreement With Merck For Versamune 16
PDS Biotechnology Corp – Key Competitors 17
PDS Biotechnology Corp – Key Employees 18
PDS Biotechnology Corp – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Corporate Communications 20
Jan 20, 2016: Immunotherapy Company PDS Biotechnology Strengthens Senior Management Team, Adds Two Drug Development Executives 20
Clinical Trials 21
Jun 07, 2016: PDS Biotechnology: CEO Frank Bedu-Addo Presenting at BIO 2016 21
Apr 13, 2016: PDS Biotechnology Reports Positive Phase 1 Study Results for PDS0101 Immunotherapy for HPV-Related Cancers 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Key Facts 2
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
PDS Biotechnology Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
PDS Biotechnology Corp, Deals By Therapy Area, 2011 to YTD 2017 8
PDS Biotechnology Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
PDS Biotech Raises USD1 Million in Venture Financing 10
PDS Biotech Raises Funds Through Venture Financing 11
PDS Biotech Raises Funds Through Venture Financing 12
NetScientific Invests in PDS Biotech 13
PDS Biotech Enters into Agreement with Merck 14
PDS Biotechnology Enters into R&D Agreement with National Cancer Institute 15
PDS Biotechnology Enters Into Licensing Agreement With Merck For Versamune 16
PDS Biotechnology Corp, Key Competitors 17
PDS Biotechnology Corp, Key Employees 18

★海外企業調査レポート[PDS Biotechnology Corp-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dover Corp (DOV):石油・ガス:M&Aディール及び事業提携情報
    Summary Dover Corp (Dover) is a diversified manufacturer of specialized industrial products and equipment. The company offers precision marketing and coding; digital textile printing; soldering and dispensing equipment; glove ports; robotic grippers; rotor and linear mechanical indexers, automation …
  • Kier Group plc (KIE):企業の財務・戦略的SWOT分析
    Kier Group plc (KIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Smartac Group China Holdings Ltd (395):企業の財務・戦略的SWOT分析
    Smartac Group China Holdings Ltd (395) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Kalvista Pharmaceuticals Inc (KALV):医療機器:M&Aディール及び事業提携情報
    Summary Kalvista Pharmaceuticals Inc (Kalvista), formerly Carbylan Therapeutics Inc, is a pharmaceutical company that discovers, develops and commercializes small molecule protease inhibitors. The company’s product candidates are inhibitors of plasma kallikrein, which is being developed for heredita …
  • Sempra Energy (SRE):企業の財務・戦略的SWOT分析
    Sempra Energy (SRE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Mannatech Inc (MTEX):企業の財務・戦略的SWOT分析
    Mannatech Inc (MTEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • DiaCarta Inc-医療機器分野:企業M&A・提携分析
    Summary DiaCarta Inc (DiaCarta) develops and commercializes molecular diagnostics products for cancer and infectious diseases. The company offers genomic testing for biomarkers and also provides clinical sample testing services in their CLIA-certified lab. It offers products such as gene mutation de …
  • ADM Tronics Unlimited Inc (ADMT):企業の財務・戦略的SWOT分析
    ADM Tronics Unlimited Inc (ADMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • HealthCare Global Enterprises Ltd (HCG):企業の財務・戦略的SWOT分析
    Summary HealthCare Global Enterprises Ltd (HCG), formerly Curie Centre of Oncology Private Ltd is a healthcare service provider that provides medical care and treatment services. The company provides services such as clinical laboratory services, diagnosis services, medical oncology services, radiat …
  • CUB Pty Ltd:企業の戦略的SWOT分析
    CUB Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • HP Inc.:企業の戦略・SWOT・財務情報
    HP Inc. - Strategy, SWOT and Corporate Finance Report Summary HP Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Services Group of America:企業の戦略・SWOT・財務分析
    Services Group of America - Strategy, SWOT and Corporate Finance Report Summary Services Group of America - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Magna International Inc.:企業の戦略・SWOT・財務情報
    Magna International Inc. - Strategy, SWOT and Corporate Finance Report Summary Magna International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Seiko Epson Corporation:企業の戦略・SWOT・財務分析
    Seiko Epson Corporation - Strategy, SWOT and Corporate Finance Report Summary Seiko Epson Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Denso Corporation:企業の戦略・SWOT・財務分析
    Denso Corporation - Strategy, SWOT and Corporate Finance Report Summary Denso Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • ICON Plc (ICLR):製薬・医療:M&Aディール及び事業提携情報
    Summary ICON plc (ICON) is a contract research organization (CRO) that provides outsourced development services to the biotechnology, pharmaceutical and medical device industries worldwide. It provides a range of specialized services that span the entire lifecycle of product development. The company …
  • Intermountain Rural Electric Association:企業の戦略的SWOT分析
    Intermountain Rural Electric Association - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • ImmunoGen Inc (IMGN)-医療機器分野:企業M&A・提携分析
    Summary ImmunoGen Inc (ImmunoGen) is a biotechnology company that carries out the development of anticancer therapeutics. The company uses its proprietary antibody-drug conjugates (ADC) technology for the development of the products. It develops products for the treatment of various types of cancer …
  • BioMarker Strategies LLC-医療機器分野:企業M&A・提携分析
    Summary BioMarker Strategies LLC (BioMarker Strategies) is a biotechnology company that develops tissue-based cancer diagnostic systems. The company offers cancer diagnostics system for predictive tests to targeted treatments for solid tumor malignancies. It also offers pathmap functional signaling …
  • Sunway REIT Management Sdn Bhd:企業の戦略・SWOT・財務情報
    Sunway REIT Management Sdn Bhd - Strategy, SWOT and Corporate Finance Report Summary Sunway REIT Management Sdn Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆